Huayuan Zhu

4PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 08, 2025
Prognostic impacts of RHOA G17V mutation in cell-free DNA assessed by droplet digital polymerase chain reaction in patients with angioimmunoblastic T-cell lymphoma.

Yi Miao, Siqi Qian, Ling Gao

|Jan 21, 2024
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.

Shuchao Qin, Rui Jiang, Luomengjia Dai

|Aug 09, 2023
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort.

Yi Miao, Yeqin Sha, Yi Xia

|Jun 20, 2023
Metronomic chemotherapy for indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

Hailing Liu, Lei Cao, Xiaoli Zhao

Pageof 1

Frequent Collaborators

3 joint publications

Lei Fan

2 joint publications

Yi Miao

2 joint publications

Yeqin Sha

2 joint publications

Jianyong Li